Guardian Investment Management Biogen Inc. Transaction History

Guardian Investment Management

$146 Million
Q2 2024

A detailed history of Guardian Investment Management transactions in Biogen Inc. stock. As of the latest transaction made, Guardian Investment Management holds 10,165 shares of BIIB stock, worth $2.04 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

10,165

Previous 10,165 -0.0%

Holding current value

$2.04 Million

Previous $2.19 Million 7.53%

% of portfolio

1.62%

Previous 1.68%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$222.59 - $267.94 $22,259 - $26,794	100 Added 0.99%	10,165 $2.63 Million
Q2 2023 Jul 14, 2023	SELL	$275.25 - $318.06 $192,675 - $222,642	-700 Reduced 6.5%	10,065 $2.87 Million
Q1 2023 May 05, 2023	BUY	$256.56 - $292.34 $153,936 - $175,403	600 Added 5.9%	10,765 $2.99 Million
Q3 2021 Oct 13, 2021	SELL	$282.99 - $369.05 $141,495 - $184,525	-500 Reduced 4.69%	10,165 $2.88 Million
Q2 2021 Jul 14, 2021	SELL	$259.0 - $414.71 $25,900 - $41,471	-100 Reduced 0.93%	10,665 $3.69 Million
Q1 2021 Apr 14, 2021	SELL	$242.95 - $284.63 $24,295 - $28,463	-100 Reduced 0.92%	10,765 $3.01 Million
Q4 2020 Jan 19, 2021	BUY	$236.26 - $355.63 $94,504 - $142,252	400 Added 3.82%	10,865 $2.66 Million
Q2 2020 Jul 13, 2020	BUY	$258.66 - $342.55 $25,866 - $34,255	100 Added 0.96%	10,465 $2.8 Million
Q1 2020 May 07, 2020	BUY	$268.85 - $341.04 $53,770 - $68,208	200 Added 1.97%	10,365 $3.28 Million
Q4 2019 Jan 15, 2020	BUY	$220.06 - $304.07 $22,006 - $30,407	100 Added 0.99%	10,165 $3.02 Million
Q3 2019 Oct 24, 2019	SELL	$217.44 - $243.88 $217,440 - $243,880	-1,000 Reduced 9.04%	10,065 $2.34 Million
Q1 2019 Apr 22, 2019	SELL	$216.71 - $338.96 $21,671 - $33,896	-100 Reduced 0.9%	11,065 $2.62 Million
Q2 2018 Jul 13, 2018	BUY	$257.52 - $306.91 $231,767 - $276,219	900 Added 8.77%	11,165 $3.24 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $208,104 - $294,328	-800 Reduced 7.23%	10,265 $2.81 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $30,764 - $34,458	-100 Reduced 0.9%	11,065 $3.53 Million
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $3.14 Million - $3.68 Million	11,165	11,165 $3.5 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Investment Management with notifications on news.

Account

Guardian Investment Management Biogen Inc. Transaction History